Vivex Biologics shared results of a new peer-reviewed study evaluating the long-term clinical and radiographic outcomes of lumbar spinal fusion procedures utilizing VIA Form+, Vivex’s cryopreserved viable bone allograft.
VIA Form+ was used as a stand-alone bone graft substitute without additional autografts or extenders. VIA Form+ allograft is a 100% tissue scaffold of demineralized cortical bone fibers coupled with cancellous chips containing endogenous bone cells to provide an optimal microenvironment for osteogenesis with excellent handling characteristics, packaged in an easy-to-use syringe.
Key findings from the study include:
100% Radiographic Fusion Success
Sustained Clinical Improvement
No Adverse Events
The study highlights the effectiveness of cryopreserved viable bone allografts as an alternative to traditional autologous iliac crest bone grafts. While the study is limited by its retrospective design and small sample size, the findings pave the way for further research into the use of cellular bone allografts in spinal surgeries.
“This long-term follow-up provides important clinical evidence supporting the sustained effectiveness of VIA Form+ as a stand-alone cellular bone matrix,” said Rey Pascual, Co-President of Vivex. “The absence of fusion deterioration, implant complications, or reoperations over three years reinforces the role of advanced [cellular bone matrices] in spinal fusion procedures, including in higher-risk patient populations.”
Vivex Biologics shared results of a new peer-reviewed study evaluating the long-term clinical and radiographic outcomes of lumbar spinal fusion procedures utilizing VIA Form+, Vivex's cryopreserved viable bone allograft.
VIA Form+ was used as a stand-alone bone graft substitute without additional autografts or extenders. VIA Form+ allograft is...
Vivex Biologics shared results of a new peer-reviewed study evaluating the long-term clinical and radiographic outcomes of lumbar spinal fusion procedures utilizing VIA Form+, Vivex’s cryopreserved viable bone allograft.
VIA Form+ was used as a stand-alone bone graft substitute without additional autografts or extenders. VIA Form+ allograft is a 100% tissue scaffold of demineralized cortical bone fibers coupled with cancellous chips containing endogenous bone cells to provide an optimal microenvironment for osteogenesis with excellent handling characteristics, packaged in an easy-to-use syringe.
Key findings from the study include:
100% Radiographic Fusion Success
Sustained Clinical Improvement
No Adverse Events
The study highlights the effectiveness of cryopreserved viable bone allografts as an alternative to traditional autologous iliac crest bone grafts. While the study is limited by its retrospective design and small sample size, the findings pave the way for further research into the use of cellular bone allografts in spinal surgeries.
“This long-term follow-up provides important clinical evidence supporting the sustained effectiveness of VIA Form+ as a stand-alone cellular bone matrix,” said Rey Pascual, Co-President of Vivex. “The absence of fusion deterioration, implant complications, or reoperations over three years reinforces the role of advanced [cellular bone matrices] in spinal fusion procedures, including in higher-risk patient populations.”
Copy to clipboard 
